ArticleNeoplasia (New York, N.Y.)2007

4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs.

Véronique Mégalizzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.